José Fuentes Pradera

Suggest Changes
  • Citations Per Year
Learn More
e11005 Background: The treatment of metastatic breast cancer HER-2 + is based on the use of chemotherapy plus trastuzumab in the first line and the use of lapatinib and capecitabine after trastuzumab(More)
  • 1